Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
European Journal of Public Health|October 2, 2009
Influence of smoking and alcohol consumption on admissions and duration of hospitalizationUlla A Hvidtfeldt, Søren Rasmussen, Morten Grønbaek, et al.
BMC Medical Informatics and Decision Making|May 21, 2021
Surrogate endpoint evaluation using data from one large global randomized controlled trialMilan Geybels, Benjamin Ole Wolthers, Frederik Flindt Kreiner, et al.
Diabetes & Vascular Disease Research|June 28, 2018
Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trialMichael A Nauck, Karen Tornøe, Søren Rasmussen, et al.
Ugeskrift for Laeger|September 3, 2008
[Genetic variations in alcohol dehydrogenase, drinking habits and alcoholism]Janne S Tolstrup, Børge G Nordestgaard, Søren Rasmussen, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 25, 2022
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practiceBernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen, et al.
The Pharmacogenomics Journal|October 10, 2007
Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genesJanne Schurmann Tolstrup, Børge Grønne Nordestgaard, Søren Rasmussen, et al.
Journal of Children'S Orthopaedics|December 4, 2012
Long-term outcome after ulnar osteotomy for missed Monteggia fracture dislocation in childrenOle Rahbek, Søren Rasmussen Deutch, Søren Kold, et al.
Medical Care|September 17, 2005
Hospital variation in mortality after first acute myocardial infarction in Denmark from 1995 to 2002: lower short-term and 1-year mortality in high-volume and specialized hospitalsSøren Rasmussen, Ann-Dorthe O Zwisler, Steen Z Abildstrom, et al.
Cardiovascular Diabetology|September 2, 2022
Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trialsOfri Mosenzon, Matthew S Capehorn, Alessandra De Remigis, et al.
Cardiovascular Diabetology|October 1, 2020
Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trialsMansoor Husain, Stephen C Bain, Anders Gaarsdal Holst, et al.
Pageof 11